281 related articles for article (PubMed ID: 33257525)
1. PPAD Activity Promotes Outer Membrane Vesicle Biogenesis and Surface Translocation by Porphyromonas gingivalis.
Vermilyea DM; Moradali MF; Kim HM; Davey ME
J Bacteriol; 2021 Jan; 203(4):. PubMed ID: 33257525
[TBL] [Abstract][Full Text] [Related]
2. Dropping anchor: attachment of peptidylarginine deiminase via A-LPS to secreted outer membrane vesicles of Porphyromonas gingivalis.
Gabarrini G; Heida R; van Ieperen N; Curtis MA; van Winkelhoff AJ; van Dijl JM
Sci Rep; 2018 Jun; 8(1):8949. PubMed ID: 29895934
[TBL] [Abstract][Full Text] [Related]
3. Conserved Citrullinating Exoenzymes in Porphyromonas Species.
Gabarrini G; Chlebowicz MA; Vega Quiroz ME; Veloo ACM; Rossen JWA; Harmsen HJM; Laine ML; van Dijl JM; van Winkelhoff AJ
J Dent Res; 2018 May; 97(5):556-562. PubMed ID: 29298553
[TBL] [Abstract][Full Text] [Related]
4. There's no place like OM: Vesicular sorting and secretion of the peptidylarginine deiminase of Porphyromonas gingivalis.
Gabarrini G; Palma Medina LM; Stobernack T; Prins RC; du Teil Espina M; Kuipers J; Chlebowicz MA; Rossen JWA; van Winkelhoff AJ; van Dijl JM
Virulence; 2018 Jan; 9(1):456-464. PubMed ID: 29505395
[TBL] [Abstract][Full Text] [Related]
5. Citrullination mediated by PPAD constrains biofilm formation in P. gingivalis strain 381.
Vermilyea DM; Ottenberg GK; Davey ME
NPJ Biofilms Microbiomes; 2019 Feb; 5(1):7. PubMed ID: 32029738
[TBL] [Abstract][Full Text] [Related]
6. Peptidyl arginine deiminase from Porphyromonas gingivalis abolishes anaphylatoxin C5a activity.
Bielecka E; Scavenius C; Kantyka T; Jusko M; Mizgalska D; Szmigielski B; Potempa B; Enghild JJ; Prossnitz ER; Blom AM; Potempa J
J Biol Chem; 2014 Nov; 289(47):32481-7. PubMed ID: 25324545
[TBL] [Abstract][Full Text] [Related]
7. The activity of bacterial peptidylarginine deiminase is important during formation of dual-species biofilm by periodontal pathogen Porphyromonas gingivalis and opportunistic fungus Candida albicans.
Karkowska-Kuleta J; Bartnicka D; Zawrotniak M; Zielinska G; Kieronska A; Bochenska O; Ciaston I; Koziel J; Potempa J; Baster Z; Rajfur Z; Rapala-Kozik M
Pathog Dis; 2018 Jun; 76(4):. PubMed ID: 29668945
[TBL] [Abstract][Full Text] [Related]
8. A Secreted Bacterial Peptidylarginine Deiminase Can Neutralize Human Innate Immune Defenses.
Stobernack T; du Teil Espina M; Mulder LM; Palma Medina LM; Piebenga DR; Gabarrini G; Zhao X; Janssen KMJ; Hulzebos J; Brouwer E; Sura T; Becher D; van Winkelhoff AJ; Götz F; Otto A; Westra J; van Dijl JM
mBio; 2018 Oct; 9(5):. PubMed ID: 30377277
[TBL] [Abstract][Full Text] [Related]
9. TLR2 Activation by
Wielento A; Bereta GP; Łagosz-Ćwik KB; Eick S; Lamont RJ; Grabiec AM; Potempa J
Front Immunol; 2022; 13():823685. PubMed ID: 35432342
[No Abstract] [Full Text] [Related]
10. Impact of Porphyromonas gingivalis Peptidylarginine Deiminase on Bacterial Biofilm Formation, Epithelial Cell Invasion, and Epithelial Cell Transcriptional Landscape.
Aliko A; Kamińska M; Bergum B; Gawron K; Benedyk M; Lamont RJ; Malicki S; Delaleu N; Potempa J; Mydel P
Sci Rep; 2018 Sep; 8(1):14144. PubMed ID: 30237466
[TBL] [Abstract][Full Text] [Related]
11. Citrullinome of
Larsen DN; Mikkelsen CE; Kierkegaard M; Bereta GP; Nowakowska Z; Kaczmarek JZ; Potempa J; Højrup P
Mol Cell Proteomics; 2020 Jan; 19(1):167-180. PubMed ID: 31754044
[No Abstract] [Full Text] [Related]
12. Identification of a new genetic variant (G231N, E232T, N235D) of peptidylarginine deiminase from
Bereta GP; Strzelec K; Łazarz-Bartyzel K; Dziedzic-Kowalska A; Nowakowska Z; Krutyhołowa A; Bielecka E; Kantyka T; Grabiec AM; Kaczmarzyk T; Chomyszyn-Gajewska M; Potempa J; Gawron K
Front Immunol; 2024; 15():1355357. PubMed ID: 38576615
[TBL] [Abstract][Full Text] [Related]
13. Structure, function, and inhibition of a genomic/clinical variant of Porphyromonas gingivalis peptidylarginine deiminase.
Bereta G; Goulas T; Madej M; Bielecka E; Solà M; Potempa J; Gomis-Rüth FX
Protein Sci; 2019 Mar; 28(3):478-486. PubMed ID: 30638292
[TBL] [Abstract][Full Text] [Related]
14. Peptidylarginine deiminase from Porphyromonas gingivalis contributes to infection of gingival fibroblasts and induction of prostaglandin E2 -signaling pathway.
Gawron K; Bereta G; Nowakowska Z; Lazarz-Bartyzel K; Lazarz M; Szmigielski B; Mizgalska D; Buda A; Koziel J; Oruba Z; Chomyszyn-Gajewska M; Potempa J
Mol Oral Microbiol; 2014 Dec; 29(6):321-32. PubMed ID: 25176110
[TBL] [Abstract][Full Text] [Related]
15. Accessory fimbrial subunits and PPAD are necessary for TLR2 activation by Porphyromonas gingivalis.
Wielento A; Bereta GP; Szczęśniak K; Jacuła A; Terekhova M; Artyomov MN; Hasegawa Y; Grabiec AM; Potempa J
Mol Oral Microbiol; 2023 Aug; 38(4):334-346. PubMed ID: 37347653
[TBL] [Abstract][Full Text] [Related]
16.
Prucsi Z; Zimny A; Płonczyńska A; Zubrzycka N; Potempa J; Sochalska M
Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37629104
[TBL] [Abstract][Full Text] [Related]
17. Spheres of influence: Porphyromonas gingivalis outer membrane vesicles.
Gui MJ; Dashper SG; Slakeski N; Chen YY; Reynolds EC
Mol Oral Microbiol; 2016 Oct; 31(5):365-78. PubMed ID: 26466922
[TBL] [Abstract][Full Text] [Related]
18. Inactivation of epidermal growth factor by Porphyromonas gingivalis as a potential mechanism for periodontal tissue damage.
Pyrc K; Milewska A; Kantyka T; Sroka A; Maresz K; Kozieł J; Nguyen KA; Enghild JJ; Knudsen AD; Potempa J
Infect Immun; 2013 Jan; 81(1):55-64. PubMed ID: 23090954
[TBL] [Abstract][Full Text] [Related]
19. Crystal structure of Porphyromonas gingivalis peptidylarginine deiminase: implications for autoimmunity in rheumatoid arthritis.
Montgomery AB; Kopec J; Shrestha L; Thezenas ML; Burgess-Brown NA; Fischer R; Yue WW; Venables PJ
Ann Rheum Dis; 2016 Jun; 75(6):1255-61. PubMed ID: 26209657
[TBL] [Abstract][Full Text] [Related]
20. Expression of anti-Porphyromonas gingivalis peptidylarginine deiminase immunoglobulin G and peptidylarginine deiminase-4 in patients with rheumatoid arthritis and periodontitis.
Shimada A; Kobayashi T; Ito S; Okada M; Murasawa A; Nakazono K; Yoshie H
J Periodontal Res; 2016 Feb; 51(1):103-11. PubMed ID: 26094771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
